Publications by authors named "M Goossens"
Article Synopsis
- The study examines how the COVID-19 pandemic affected colorectal cancer screening rates and intervals in Flanders, Belgium, focusing on the impact of socioeconomic status (SES).
- Analysis revealed that during the pandemic, areas with lower population density and lower income saw decreases in screening uptake, while wealthier areas tended to have increased delays in screening intervals.
- The findings suggest a need for targeted communication strategies to encourage screening participation among low SES populations and timely reminders for those delaying their screenings.
Background: Clinical risk factors of deficient immune responses to COVID-19 mRNA vaccination in SARS-CoV-2 naive hemodialysis recipients (HDR) have already been identified. Clinical factors influencing hybrid immunity induced by SARS-CoV-2 infection and vaccination in HDR have not been reported.
Methods: A comprehensive analysis of antibody (Ab) and T cell responses to two doses of BNT162b2 mRNA vaccination was performed in 103 HDR, including 75 SARS-CoV-2 naive and 28 experienced patients, and in 106 healthy controls (HC) not undergoing HD, including 40 SARS-CoV-2 naive and 66 experienced subjects.
Background: Small fiber neuropathy (SFN) is a chronic neuropathic pain condition that can lead to a decreased quality of life (QOL) and disability. Current pain treatment is mainly symptomatic, consisting of analgesics, with often disappointing results. There is a need for new, more effective treatment modality.
View Article and Find Full Text PDFArticle Synopsis
- Patients with post-COVID-19 condition (PCC) face various complaints that significantly affect their daily lives, but there's a lack of effective rehabilitation treatments tailored to their needs.* -
- The study focuses on evaluating a new, person-centered interdisciplinary rehabilitation program designed to enhance the social participation and quality of life of COVID-19 patients dealing with high disability levels.* -
- The research will include 20 Dutch adults in a structured trial with three phases: an observational baseline, a 12-week personalized treatment phase, and a 12-week follow-up, measuring outcomes through daily diaries and validated questionnaires.*
Lung transplant recipients (LTRs) are susceptible to severe Coronavirus Disease 2019 (COVID-19) and had lower immune responses to primary severe acute respiratory syndrome-related to coronavirus 2 (SARS-CoV-2) vaccination as compared to the general population and to other solid organ transplant recipients. As immunity induced by booster vaccination and natural infection has increased since the beginning of the pandemic in the general population, immunity acquired by LTRs is not well documented. Humoral and cellular immunity to SARS-CoV-2 was monitored in February and May 2023 in 30 LTRs and compared to that of health care workers (HCWs) and nursing home residents (NHRs).
View Article and Find Full Text PDF